Filing Details
- Accession Number:
- 0001213900-23-088896
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-20 20:14:16
- Reporting Period:
- 2023-11-16
- Accepted Time:
- 2023-11-20 20:14:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1788028 | Jasper Therapeutics Inc. | JSPR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208907 | G Thomas Wiggans | C/O Jasper Therapeutics, Inc. 2200 Bridge Pkwy, Suite 102 Redwood City CA 94065 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Voting Common Stock | Acquisiton | 2023-11-16 | 10,000 | $0.60 | 10,000 | No | 4 | P | Direct | |
| Voting Common Stock | Acquisiton | 2023-11-17 | 10,000 | $0.60 | 20,000 | No | 4 | P | Direct | |
| Voting Common Stock | Acquisiton | 2023-11-20 | 10,000 | $0.63 | 30,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5889 to $0.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.616 to $0.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
